|
TANAKA Junji
Department Other, Other Position |
|
| Article types | Original article |
| Language | English |
| Peer review | Peer reviewed |
| Title | Correction to: Fractionated ifosfamide, carboplatin, and etoposide with rituximab as a safe and effective treatment for relapsed/refractory diffuse large B cell lymphoma with severe comorbidities. |
| Journal | Formal name：Annals of hematology Abbreviation：Ann Hematol ISSN code：14320584/09395555 |
| Domestic / Foregin | Foregin |
| Volume, Issue, Page | 99(11),pp.2587 |
| Author and coauthor | Tanaka Norina†, Imai Yoichi, Yoshinaga Kentaro, Shiseki Masayuki, Tanaka Junji |
| Authorship | Last author |
| Publication date | 2020/11 |
| Summary | In the published online paper, the data "p = 0.144" was not deleted from the line "Median and mean number of prior treatments (range)" in Table 4. |
| DOI | 10.1007/s00277-020-04288-9 |
| PMID | 32980889 |